Andrew Guggenhime - 23 Dec 2021 Form 4 Insider Report for Vaxcyte, Inc. (PCVX)

Role
President and CFO
Signature
/s/ Ron Metzger, Attorney-in-Fact
Issuer symbol
PCVX
Transactions as of
23 Dec 2021
Net transactions value
-$57,815
Form type
4
Filing time
28 Dec 2021, 15:13:58 UTC
Previous filing
21 Dec 2021
Next filing
03 Mar 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PCVX Common Stock Options Exercise $16,585 +3,100 +99% $5.35 6,225 23 Dec 2021 Direct
transaction PCVX Common Stock Sale $74,400 -3,100 -50% $24.00 3,125 23 Dec 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PCVX Stock Option (right to buy) Options Exercise $0 -3,100 -0.59% $0.000000 518,418 23 Dec 2021 Common Stock 3,100 $5.35 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.
F2 1/4 of the shares subject to the option vested on May 1, 2021, and 1/48 of the shares vest monthly thereafter.